A previous study indicated that finasteride could potentially inhibit the expression of Insulin-like Growth Factor 1(IGF-1) by suppressing the activity of c-JUN within fibroblasts in benign prostate tissue, leading to a reduction in the synthesis and secretion of IGF-1 (Wang et al., 2017). Here, JUN is linked to medical procedure.